Correction: Isatin-based benzyloxybenzene derivatives as monoamine oxidase inhibitors with neuroprotective effect targeting neurodegenerative disease treatment. [PDF]
RSC AdvBenny F +9 more
europepmc +1 more source
[Monoamine oxidase inhibitors].
Fortschritte der Arzneimittelforschung. Progress in drug research. Progres des recherches pharmaceutiques, 1998 A, PLETSCHER, K F, GEY, P, ZELLER
+6 more sources
Novel hydrazine molecules as tools to understand the flexibility of vascular adhesion protein-1 ligand-binding site: toward more selective inhibitors [PDF]
, 2011 Fülöp Ferenc +5 more
core +1 more source
Novel C7-Substituted Coumarins as Selective Monoamine Oxidase Inhibitors: Discovery, Synthesis and Theoretical Simulation. [PDF]
Molecules, 2019 Wang D +6 more
europepmc +1 more source
Different Generations of Type-B Monoamine Oxidase Inhibitors in Parkinson's Disease: From Bench to Bedside. [PDF]
Curr Neuropharmacol, 2019 Alborghetti M, Nicoletti F.
europepmc +1 more source
Metabolic Control Analysis in a Cellular Model of Elevated MAO-B: Relevance to Parkinson’s Disease [PDF]
, 2009 Jyothi K. Mallajosyula +38 more
core +1 more source
Concurrent use of ketamine and monoamine oxidase inhibitors in the treatment of depression: A letter to the editor. [PDF]
Gen Hosp Psychiatry, 2018 Katz RB +4 more
europepmc +1 more source
Probing Multi-Target Action of Phlorotannins as New Monoamine Oxidase Inhibitors and Dopaminergic Receptor Modulators with the Potential for Treatment of Neuronal Disorders. [PDF]
Mar Drugs, 2019 Seong SH +6 more
europepmc +1 more source
3D-QSAR and in-silico Studies of Natural Products and Related Derivatives as Monoamine Oxidase Inhibitors. [PDF]
Curr Neuropharmacol, 2018 Dhiman P, Malik N, Khatkar A.
europepmc +1 more source
Ultrasonic vocalizations as a predictor of resilience to intermittent swim stress-induced anxiety: An investigation of re-exposure effects [PDF]
, 2016 Drugan, Robert C +2 more
core +2 more sources